
First-in-class treatments for aggressive, "undruggable" cancers
Z Prime Therapeutics is a precision oncology therapeutics biotechnology company developing first-in-class treatments for aggressive, "undruggable" cancers. The company exploit a novel synthetic lethal relationship involving mRNA quality control machinery in cancer cells.
Boutique Venture Partners backs authentic founders who transform industries and create new ones in healthcare and life sciences.